Carbogen Amcis (Swiss-based pharma process development and API manufacturing company) has opened a new office located in Kyoto, Japan.
Japan flag
The new Dishman Carbogen Amcis Japan marks another milestone for the company, which is already actively serving the Japanese market for APIs development and commercialization services. The office forms part of the company’s commitment to increase its presence in Japan and other Asia-Pacific markets.
“The Japanese market is expanding and we face a growing demand from Japanese customers. Having a local presence will help to bring new opportunities and support the existing business more closely,” said Pascal Villemagne, vice president, sales & marketing. “This new office will allow us to strengthen our existing customer relationships and help them understand our full capabilities — enabling more business opportunities and future growth.”
“My mission is to establish Dishman Carbogen Amcis Japan and start up all business activities in the local office. I am thrilled to participate to this new opening,” explained Paul Kuad, sales manager for the Japan territory who has relocated from Switzerland. “The team will grow in the coming weeks as we hire local resources to support the sales team.”
“We recognise that Japan plays a critical role in today’s pharmaceutical industry and we want to demonstrate to our customers that we value our collaborations. Opening a Japanese office will allow us to better serve our customers and strengthen our local relationships,” added Mark Griffiths, Dishman Carbogen Amcisgroup CEO. “In addition, the office will represent a strong advantage to further expand our business development aspirations in the Asia-Pacific arena.”